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Abstract 23 
Ozone-based treatment trains offer a sustainable option for potable reuse applications, but 24 
nitrosamine formation during ozonation poses a challenge for municipalities seeking to avoid 25 
reverse osmosis and high-dose ultraviolet (UV) irradiation. Six nitrosamines were monitored in 26 
full-scale and pilot-scale wastewater treatment trains. The primary focus was on eight treatment 27 
trains employing ozonation of secondary or tertiary wastewater effluents, but two treatment 28 
trains with chlorination or UV disinfection of tertiary wastewater effluent and another with full 29 
advanced treatment (i.e., reverse osmosis and advanced oxidation) were also included for 30 
comparison. N-nitrosodimethylamine (NDMA) and N-nitrosomorpholine (NMOR) were the 31 
most prevalent nitrosamines in untreated (up to 89 ng/L and 67 ng/L, respectively) and treated 32 
wastewater. N-nitrosomethylethylamine (NMEA) and N-nitrosodiethylamine (NDEA) were 33 
detected at one facility each, while N-nitrosodipropylamine (NDPrA) and N-nitrosodibutylamine 34 
(NDBA) were less than their method reporting limits (MRLs) in all samples. Ozone-induced 35 
NDMA formation ranging from <10 to 143 ng/L was observed at all but one site, but the reasons 36 
for the variation in formation remain unclear. Activated sludge, biological activated carbon 37 
(BAC), and UV photolysis were effective for NDMA mitigation. NMOR was also removed with 38 
activated sludge but did not form during ozonation. 39 
 40 
Keywords: Wastewater, ozone, nitrosamine, N-nitrosodimethylamine (NDMA), potable reuse. 41 
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List of Abbreviations 42 
AFU  Arbitrary fluorescence unit 43 
AMU  Atomic mass unit 44 
AOP  Advanced oxidation process 45 
ASPE  Automated solid phase extraction 46 
BAC  Biological activated carbon 47 
BOD  Biochemical oxygen demand 48 
BPR  Biological phosphorus removal 49 
CA  California 50 
CAS  Conventional activated sludge 51 
CCL3  Contaminant Candidate List 3 52 
CDPH  California Department of Public Health 53 
CEC  Contaminant of emerging concern 54 
DN  Denitrification 55 
DOC  Dissolved organic carbon 56 
DWEL  Drinking water equivalent level 57 
EBCT  Empty bed contact time 58 
EEM  Excitation emission matrix 59 
EfOM  Effluent organic matter 60 
EPA  Environmental Protection Agency 61 
GA  Georgia 62 
GF  Gravity filtration 63 
IRIS  Integrated Risk Information System 64 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
KY  Kentucky 65 
MBR  Membrane bioreactor 66 
MDL  Method detection limit 67 
MF  Microfiltration 68 
MO  Missouri 69 
MRL  Method reporting limit 70 
N  Nitrification 71 
N/A  Not available or not applicable 72 
NDBA  N-nitrosodibutylamine 73 
NDEA  N-nitrosodiethylamine 74 
NDMA N-nitrosodimethylamine 75 
NDPhA N-nitrosodiphenylamine 76 
NDPrA N-nitrosodipropylamine 77 
NMEA N-nitrosomethylethylamine 78 
NMOR N-nitrosomorpholine 79 
NPIP  N-nitrosopiperidine 80 
NPYR  N-nitrosopyrrolidine 81 
NV  Nevada 82 
OD  Oxidation ditch 83 
PAC  Powdered activated carbon 84 
QLD  Queensland 85 
RO  Reverse osmosis 86 
RSD  Relative standard deviation 87 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
SRT  Solids retention time 88 
SUVA  Specific UV254 absorbance 89 
TOC  Total organic carbon 90 
TX  Texas 91 
UDMH Unsymmetrical dimethylhydrazine 92 
UF  Ultrafiltration 93 
U.S.  United States 94 
UV  Ultraviolet 95 
96 
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1.0 Introduction 97 
Nitrosamines are disinfection byproducts commonly associated with chloramination 98 
(Choi and Valentine, 2002; Mitch et al., 2003a; Mitch et al., 2005; Krasner et al., 2013), but 99 
recent studies indicate that ozone-induced formation of N-nitrosodimethylamine (NDMA) is also 100 
a potential problem (Andrzejewski et al., 2008; Oya et al., 2008; Schmidt and Brauch, 2008; 101 
Hollender et al., 2009; Kosaka et al., 2009; Yang et al., 2009; Yoon et al., 2011; von Gunten, et 102 
al., 2010; Nawrocki and Andrzejewski, 2011; Pisarenko et al., 2012; Gerrity et al., 2014). 103 
NDMA is also a byproduct of the rubber, dye, tanning, and pesticide industries, and it has been 104 
found in groundwater near sites that produce rocket fuel containing unsymmetrical 105 
dimethylhydrazine (UDMH) (Mitch et al., 2003b). 106 
In contrast with many contaminants of emerging concern (CECs) (Bull et al., 2011), 107 
nitrosamines are relevant to public health even at the ng/L level. For example, the United States 108 
(U.S.) Environmental Protection Agency’s (EPA) Integrated Risk Information System (IRIS) 109 
indicates that NDMA is a probable human carcinogen with an oral slope factor of 51 (mg/kg-d)-1 110 
(EPA, 2012). This corresponds to a drinking water equivalent level (DWEL) of 0.69 ng/L based 111 
on an acceptable lifetime risk of 10-6, a body weight of 70 kg, and a drinking water consumption 112 
rate of 2 L/d. Other nitrosamines, including N-nitrosomethylethylamine (NMEA), N-113 
nitrosodipropylamine (NDPrA), N-nitrosodibutylamine (NDBA), and N-nitrosopyrrolidine 114 
(NPYR), have DWELs below 20 ng/L, and the DWEL for N-nitrosodiethylamine (NDEA) is 115 
even lower than that of NDMA at 0.23 ng/L (EPA, 2012).  116 
These low public health thresholds are particularly problematic for potable reuse systems 117 
due to the prevalence of nitrosamines and their precursors in wastewater. In fact, nitrosamines 118 
are a significant driver in treatment train selection for potable reuse systems throughout the 119 
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world (Gerrity et al., 2013; Gerrity et al., 2014). Nitrosamines are not yet regulated at the federal 120 
level in the United States (U.S.), but NDMA, NDEA, NDPrA, NPYR, and N-121 
nitrosodiphenylamine (NDPhA) are all listed on the U.S. EPA’s Contaminant Candidate List 3 122 
(CCL3) (EPA, 2009). At the state level, the California Department of Public Health (CDPH) has 123 
established drinking water notification levels of 10 ng/L for NDMA, NDEA, and NDPrA 124 
(CDPH, 2010). The Australian Drinking Water Guidelines specify a value of 100 ng/L for 125 
NDMA (NHMRC, 2011), and the Australian Guidelines for Water Recycling specify a more 126 
stringent target of 10 ng/L for NDMA and NDEA (EPHC, 2008). Canada has also established a 127 
40 ng/L maximum acceptable concentration for NDMA (Health Canada, 2011). These regulatory 128 
agencies face the predicament of balancing public health goals, the industry’s current analytical 129 
capabilities, and practical limits of treatability. The method reporting limits (MRLs) for NDMA 130 
and NDEA exceed their corresponding DWELs, and the MRLs for other nitrosamines provide 131 
insufficient sensitivity to allow for lower guidelines or regulatory limits (EPA, 2004; Holady et 132 
al., 2012). 133 
The characteristics of nitrosamines also make them a significant environmental and 134 
engineering concern. Studies indicate that NDMA is miscible with water and has low sorption 135 
potential (Kommineni et al., 2003). This makes NDMA very mobile in the environment and 136 
problematic for groundwater replenishment applications. NDMA is also highly resistant to 137 
oxidation (Pisarenko et al., 2012) due to its low concentration and relatively low second order 138 
rate constants with ozone (5.3x10-2 M-1 s-1; Lee et al., 2007) and short-lived hydroxyl radicals 139 
(4.6x108 M-1 s-1; Lee et al., 2007) This recalcitrance is exacerbated by direct formation when 140 
ozone reacts with NDMA precursors present in some wastewater matrices. NDMA mitigation is 141 
typically achieved with biodegradation (Sharp et al., 2005; 2010; Krauss et al., 2010), reverse 142 
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osmosis (RO) (Plumlee et al., 2008), or ultraviolet (UV) photolysis (Bolton et al., 2002; 143 
Sharpless and Linden, 2003; Lee et al., 2005a; Lee et al., 2005b), although the required UV 144 
doses (i.e., generally >100 mJ/cm2) can be cost prohibitive. 145 
Recent risk assessments indicate that ‘planned’ potable reuse can be more protective of 146 
public health than ‘unplanned’ indirect potable reuse or conventional drinking water systems 147 
(NRC, 2012). However, pervasive uncertainty in the industry is potentially leading to the 148 
overdesign of advanced treatment facilities for potable reuse (Gerrity et al., 2013). A majority of 149 
the recently constructed potable reuse facilities employ “full advanced treatment” (CDPH, 2013), 150 
which includes RO and an advanced oxidation process (AOP). These systems typically include 151 
microfiltration (MF) for pretreatment, chloramination to control biological fouling, and UV/H2O2 152 
as the preferred AOP due to the formation of NDMA during chloramination. Treatment trains 153 
employing ozone and biological activated carbon (BAC) offer a more sustainable alternative in 154 
terms of economic costs and energy consumption (Gerrity et al., 2014), and they are also capable 155 
of achieving similar water quality objectives, including CEC mitigation and pathogen 156 
inactivation (Reungoat et al., 2010; Gerrity et al., 2011; Reungoat et al., 2012; Gerrity et al., 157 
2014). The combination of ozone and biological sand filtration has also been studied in Europe 158 
with respect to CEC mitigation and toxicity (Hollender et al., 2009; Stalter et al., 2010a; 2010b). 159 
Several ozone-based potable reuse treatment trains have been operating in the U.S. for years with 160 
no documented adverse public health impacts.  161 
Despite the advantages of implementing ozone in wastewater applications, the potential 162 
for nitrosamine formation poses a significant threat to the viability of this technology for future 163 
potable reuse systems. NDMA formation in ozone applications is typically low (i.e., <10 ng/L) 164 
(Hollender et al., 2009; Zimmerman et al., 2011), but some matrices lead to formation in excess 165 
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of 50-100 ng/L (Kosaka et al., 2009; Yoon et al., 2011; Gerrity et al., 2014). Some studies have 166 
identified potential precursors (Andrzejewski et al., 2008; Kosaka et al., 2009; von Gunten et al., 167 
2010; Marti et al., 2014), but, in general, little is known regarding the formation pathway and the 168 
reasons for the significant variability observed between wastewater matrices. Furthermore, 169 
studies often focus on NDMA and fail to address the other nitrosamines that pose similar risks to 170 
public health. 171 
The objective of this study was to address these knowledge gaps by monitoring the 172 
occurrence of six nitrosamines (NDMA, NMEA, NDEA, NDPrA, N-nitrosomorpholine (NMOR), 173 
and NDBA) in full-scale and pilot-scale treatment trains with a range of operational conditions. 174 
The primary focus was on eight treatment trains employing ozonation of secondary or tertiary 175 
wastewater effluents, but two treatment trains with chlorination or UV disinfection of tertiary 176 
wastewater effluent and another with full advanced treatment were also included for comparison. 177 
This study provides a survey of nitrosamine occurrence and formation and explores the 178 
operational conditions that contribute to the observed range in concentrations. This research 179 
contributes to the development of nitrosamine mitigation strategies, which will facilitate broad 180 
implementation of ozone-based potable reuse treatment trains. 181 
 182 
2.0.  Materials and Methods 183 
2.1. Study Sites and Sampling Locations 184 
Grab samples were collected from 11 different full-scale or pilot-scale treatment trains in 185 
the U.S. and Australia. The study sites, operational conditions, and sampling dates are 186 
summarized in Table 1, and more detailed descriptions of the study sites, including treatment 187 
train schematics and general water quality information, are provided in the Supplementary 188 
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Information (SI). The sampling plan included six full-scale and two pilot-scale systems with 189 
ozone, two conventional wastewater treatment plants with chlorination or UV disinfection, and 190 
one full advanced treatment facility. Grab samples were collected at various points throughout 191 
each treatment train to fully characterize nitrosamine occurrence and formation, but special 192 
attention was given to sampling locations before and after secondary treatment, ozonation, and 193 
BAC. Several sites employ solids handling processes, including belt filter presses, dewatering 194 
centrifuges and/or anaerobic digesters, supplemented with polymer addition. The associated 195 
returns flows are often recombined with influent or primary effluent for further treatment, which 196 
could impact nitrosamine occurrence and formation. Therefore, digester supernatant was also 197 
sampled at one of the sites (Site B). 198 
The facilities encompass a variety of biological treatment conditions with solids retention 199 
times (SRTs) ranging from 1.5-36 days. The membrane bioreactor (MBR) at the Site J2 pilot was 200 
also operated in multiple modes (i.e., biochemical oxygen demand (BOD) removal with SRT = 201 
2.4 days vs. nitrification/denitrification with SRT = 18.8 days) to evaluate the impacts of 202 
biological treatment on downstream NDMA formation during ozonation. The number of ozone 203 
application points ranged from one to three, and the ozone to dissolved or total organic carbon 204 
ratios (O3/DOC or O3/TOC) ranged from 0.2-1.5. The O3/DOC or O3/TOC ratio has been 205 
identified as a useful parameter for predicting ozone performance with respect to chemical 206 
oxidation (Gerrity et al., 2012; Lee et al., 2013) and microbial inactivation (Gerrity et al. 2012; 207 
Gamage et al, 2013) in different secondary and tertiary effluents. The Site H and Site J2 pilots 208 
were tested at different O3/TOC or O3/DOC ratios to determine whether the applied ozone dose 209 
was correlated with NDMA formation. Finally, the empty bed contact times (EBCTs) in the 210 
BAC processes ranged from 15-18 minutes. 211 
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General water quality information was provided by the participating utilities for some 212 
samples (see SI). All other nitrosamine and effluent organic matter (EfOM) data were analyzed 213 
using the methods described below.  214 
2.2. Target Nitrosamines and Analytical Methods  215 
All chemicals and solvents were purchased from commercial suppliers at 95% purity or 216 
higher (details provided in SI Text S12). Nitrosamine samples were collected in 1-L, pre-cleaned, 217 
pre-silanized amber glass bottles. Aliquots of sodium azide (1 g/L) and sodium thiosulfate (800 218 
mg/L) were added to bottles prior to sampling for preservation and to quench residual oxidant. 219 
After sampling, bottles were kept on ice during transportation or shipping and then stored at 4°C 220 
until extraction. Samples were filtered with 90 mm glass microfiber (GF/F) filters (Whatman, 221 
GE Healthcare Bio-Sciences, Pittsburgh, PA) and extracted within 14 days of collection.  222 
Nitrosamine analysis was performed with isotope dilution using a modified version of 223 
U.S. EPA method 521 (Holady et al., 2012). A detailed description of the method is provided in 224 
SI Text S12, and a brief description is provided below. Automated solid phase extraction (ASPE) 225 
was performed using a Dionex AutoTrace workstation (Thermo Scientific, Sunnyvale, CA, 226 
USA). A Varian (Walnut Creek, CA) CP-3800 Gas Chromatograph with a CP-8400 auto sampler 227 
was used for separation, and a Varian 4000 ion trap mass spectrometer was used for analysis in 228 
conjunction with multiple reaction monitoring in positive chemical ionization mode. Some of the 229 
nitrosamines did not exhibit a second product ion in sufficient abundance for transition 230 
confirmation and therefore only have one quantitation transition. Due to thermal degradation 231 
upon injection, NDPhA was analyzed as diphenylamine during a preliminary 14-day holding 232 
study (see Table S42). MRLs were established at 3 to 5 times the calculated method detection 233 
limit (MDL) (n=12). A field blank was collected for each sampling event, extracted, and 234 
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analyzed. A laboratory reagent blank was also included in each extract batch. Acceptable 235 
average percent recoveries were limited to 70-130%, and acceptable relative standard deviations 236 
(RSDs) were limited to 30% for replicate samples. Average percent recoveries and RSDs in 237 
reagent water, finished drinking water, surface water, and tertiary wastewater effluent are 238 
summarized in Table S44. 239 
The initial target compound list included NDMA, NMEA, NDEA, NDPrA, NMOR, 240 
NDBA, NPYR, N-nitrosopiperidine (NPIP), and NDPhA. Primary effluent, secondary effluent, 241 
combined ozone influent, and ozone effluent from Site A were collected in October 2011 for 242 
preliminary method development. Matrix interference resulted in unreliable quantification for 243 
NPYR and NPIP, particularly in the primary effluent, so these compounds were eliminated from 244 
the target compound list. A 14-day holding study was then performed on the remaining seven 245 
nitrosamines with deionized water and primary effluent from Site J1 (Table S42). Nine samples 246 
of each matrix were spiked with 1 µg/L of each nitrosamine. Each sample was preserved with 247 
sodium azide (1 g/L) and held at room temperature to simulate a ‘worst-case’ scenario during 248 
shipping. Triplicate samples were analyzed on day 0, day 7, and day 14. Of the seven 249 
nitrosamines, only NDPhA showed a consistent decrease in concentration over the 14-day 250 
holding period. A 75% decrease in concentration was observed after 7 days, and the 251 
concentration was <MRL after 14 days. However, the decrease does not appear to be attributable 252 
to biodegradation since it was observed in both matrices.  253 
Based on the matrix effects associated with NPYR and NPIP and the instability of 254 
NDPhA, the final target compound list was limited to NDMA, NMEA, NDEA, NDPrA, NMOR, 255 
and NDBA. These compounds are summarized along with their corresponding isotopes, 256 
precursor and product ions used for quantitation and confirmation, molecular weights, and MRLs 257 
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in Table S43. The MRLs in Table S43 apply to all wastewater matrices except primary effluent, 258 
for which each MRL was five times higher, and the samples from Site G, which allowed for 259 
lower MRLs due to reduced matrix interference. Matrix-specific MRLs are provided in the SI for 260 
each site.  261 
2.3. Effluent Organic Matter Characterization 262 
EfOM characterization included TOC or DOC, UV absorbance (220-580 nm), specific 263 
UV254 absorbance (SUVA), and fluorescence. For the TOC and DOC analyses, samples were 264 
collected in glass vials and acidified to pH <3 with hydrochloric acid. Samples with visible 265 
suspended solids were filtered in the laboratory through 0.45-µm membranes (GHP Acrodisk, 266 
Pall Life Sciences) and reported as DOC; laboratory filtration was also performed prior to the 267 
UV-Vis and fluorescence analyses. Samples filtered at pilot-scale or full-scale with membrane 268 
filtration were also reported as DOC. A total organic carbon/total nitrogen analyzer (Shimadzu 269 
Scientific Instruments, Carlsbad, CA) was used for quantification. Sample absorbance was 270 
measured using a Perkin-Elmer Lambda 45 UV-VIS Spectrometer, consistent with Standard 271 
Method 5910 B. Excitation emission matrices (EEMs) were created using a QuantaMaster UV-272 
Vis QM4 Steady State Spectrofluorometer (Photon Technology International, Inc., Birmingham, 273 
NJ). The spectrofluorometer included a 75-watt, short-arc xenon lamp with an excitation range 274 
from 240-1,200 nm. Data processing in MATLAB (MathWorks, Natick, MA) included 275 
corrections for blank response, the spectral sensitivity of the lamp, and the inner filter effect. The 276 
fluorescence data were also normalized to an average Raman peak area, which was based on 277 
excitation at 350 nm and emission from 380-410 nm in deionized water. Regional integration 278 
was performed according to published literature (Chen et al., 2003; Gerrity et al., 2011; Stanford 279 
et al., 2011) to calculate the regional and total fluorescence intensities in arbitrary fluorescence 280 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
14 
units (AFU). Integration was based on three regions representing (I) microbial byproducts, 281 
proteins, and biopolymers; (II) fulvic-like substances; and (III) humic-like substances. These 282 
regions are defined and illustrated in Table S45 and Figure S26, respectively. The EfOM data are 283 
referenced throughout the text, but the raw data and figures are provided in the SI. 284 
 285 
3.0. Results and Discussion 286 
Only six of the original nine nitrosamines were included in the final target compound list. 287 
Two of the remaining six nitrosamines (NDPrA and NDBA) were <MRL (100 ng/L in primary 288 
effluent and 20 ng/L in other matrices) for all sampling locations at all study sites. With less 289 
complex matrices, such as those at Site G, lower reporting limits are possible for these 290 
compounds, but in more complex wastewater effluents, it is difficult to evaluate these 291 
compounds in the context of their toxicological thresholds and/or regulatory guideline values 292 
(e.g., 10 ng/L for NDPrA in California). NMEA was detected in two locations at Site C, and 293 
NDEA was detected in two locations at Site E. These compounds were not detected at any other 294 
sites.  295 
NDMA and NMOR proved to be the most prevalent compounds based on the sample 296 
matrices and analytical capabilities in this study. As observed in other studies (Hollender et al., 297 
2009; Zimmerman et al., 2011; Yoon et al., 2011), there was a clear relationship between 298 
ozonation and NDMA formation at all but Site C (Figure 1), while NMOR concentrations 299 
remained relatively constant or possibly decreased during ozonation (Figure 2). In addition, 300 
biodegradation via secondary treatment proved to be an effective mitigation measure for both 301 
NDMA (Sites B, D, and E; Figure 1) and NMOR (Sites A and B; Figure 2). Decreases in NDMA 302 
concentration after secondary treatment have also been reported in the literature (Sedlak et al., 303 
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2005; Krauss et al., 2010). Biodegradation of NDMA was also observed in two BAC systems 304 
(Sites D and F), but BAC did not appear to be effective for NMEA degradation (NMEA only 305 
observed at Site C). Site-specific summaries and pilot-scale evaluations of O3/DOC or O3/TOC 306 
and biological treatment mechanisms are provided below. 307 
3.1 Full-Scale Site A (MO, USA) 308 
Two sets of samples were collected from Train #2 at Site A, which includes conventional 309 
activated sludge (SRT = 18-20 days) with nitrification and biological phosphorus removal. The 310 
sampling locations included primary influent, primary effluent, secondary effluent, combined 311 
ozone influent (combination of biologically treated and filtered wastewater from both trains), and 312 
ozone effluent (O3/DOC = 1.0-1.2). The process stream also includes return flows from solids 313 
handling processes supplemented with polymer addition. Detailed descriptions of the treatment 314 
trains, sampling locations, and general water quality are provided in Text S1 in the SI.  315 
Based on the EfOM characterization (see SI), the primary and secondary effluents from 316 
October 2011 exhibited higher levels of UV absorbance and fluorescence but lower DOC 317 
concentrations than the samples from May 2012. The October 2011 secondary effluent also had a 318 
higher concentration of NDMA (11 ng/L vs. 7.8 ng/L), but NMOR concentrations were higher 319 
for the May 2012 primary (<50 ng/L vs. 58 ng/L) and secondary effluents (12 ng/L vs. 22 ng/L). 320 
The high-SRT biological process achieved significant reductions in total nitrogen (TN); EfOM, 321 
including a ~50% reduction in total fluorescence; and NMOR (from 58 ng/L to 22 ng/L in May 322 
2012). Similar comparisons of biological treatment efficacy were not possible for NDMA or 323 
NMOR in October 2011 because the corresponding concentrations were <MRL. 324 
NMOR remained relatively constant during ozonation, which is consistent with the 325 
literature (Hollender et al. 2009; Zimmermann et al. 2011), but ozone-induced formation of 326 
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NDMA was observed in both sample events (formation of 14 ng/L and 7.7 ng/L for total 327 
concentrations of 26 ng/L and 14 ng/L). NDMA formation may have been higher in the October 328 
2011 sample due to the more complex EfOM, as indicated by the higher UV254 absorbance 329 
(0.116 cm-1 vs. 0.108 cm-1) and fluorescence values (28,782 AFU vs. 23,525 AFU), and/or the 330 
greater extent of oxidation, as indicated by differential UV254 absorbance (reduction of 49% vs. 331 
39%) and differential total fluorescence (reduction of 84% vs. 76%). Despite the quantifiable 332 
increase in NDMA, the change was relatively minor compared to that of other ozonated 333 
secondary effluents (i.e., >100 ng/L in Gerrity et al. (2014)). The finished effluent, which is 334 
discharged to a nearby surface water, contained NDMA and NMOR concentrations of 14-26 335 
ng/L and <MRL-22 ng/L, respectively.   336 
3.2 Full-Scale Site B (KY, USA) 337 
Preliminary effluent (post-headworks), clarifier effluent (post-oxidation ditch; SRT = 338 
N/A; nitrification and partial denitrification), ozone effluent (O3/TOC = 0.9), and digester 339 
supernatant were collected from Site B. Digester supernatant is returned to the process flow prior 340 
to biological treatment in the oxidation ditch. Detailed descriptions of the treatment train, 341 
sampling locations, and general water quality are provided in Text S2 in the SI. 342 
The oxidation ditch at this facility produces a high quality effluent, as indicated by the 343 
low UV254 absorbance (0.076 cm-1) and total fluorescence (18,145 AFU) values. Similar to Site 344 
A, the biological process reduced the concentrations of NDMA and NMOR from 25 ng/L to <5 345 
ng/L and 67 ng/L to 21 ng/L, respectively. The concentration of NMOR remained relatively 346 
constant (20 ng/L) after ozonation, but the concentration of NDMA increased just above the 347 
MRL to 5.2 ng/L. The extent of oxidation was consistent with that of Site A, considering the 348 
UV254 absorbance and total fluorescence decreased by 42% and 78%, respectively. With respect 349 
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to solids handling, digester supernatant proved to be a relatively minor contributor of individual 350 
nitrosamines in that NMOR was the only compound >MRL (13 ng/L). However, digester 351 
supernatant may still contribute precursors responsible for chloramine-induced or ozone-induced 352 
nitrosamine formation (Padhye et al., 2011). The finished effluent from this facility, which is 353 
discharged to a nearby surface water, contained 5.2 ng/L of NDMA and 20 ng/L of NMOR. 354 
3.3 Full-Scale Site C (TX, USA) 355 
 The treatment train at Site C includes primary clarifiers, activated sludge (SRT = 10 days) 356 
with nitrification and powdered activated carbon (PAC) addition, secondary clarifiers, 357 
denitrification (SRT = 36 days) with methanol addition, tertiary clarifiers, lime addition, 358 
recarbonation, sand filtration, ozonation (O3/TOC = 0.3), and BAC (EBCT = 16 min) prior to 359 
direct injection into the local aquifer. Primary effluent, tertiary clarifier effluent, sand filter 360 
effluent, ozone effluent, and BAC effluent were collected for analysis. Detailed descriptions of 361 
the treatment train, sampling locations, and general water quality are provided in Text S3 in the 362 
SI. 363 
NMEA was the only nitrosamine detected at this facility, and the concentrations were 6.3 364 
ng/L and 7.6 ng/L in the ozone effluent and BAC effluent, respectively. Since the NMEA in the 365 
ozone effluent was only slightly higher than the MRL and the fact that NMEA was not detected 366 
at any other facilities, it is not possible to definitively link its presence to ozone-induced 367 
formation. In addition, Site C was the only facility for which NDMA did not exhibit a 368 
quantifiable increase during ozonation. This is possibly due to a combination of the low EfOM 369 
content of the ozone influent and the relatively low O3/TOC ratio in comparison to other 370 
facilities in this study. The lack of measurable NDMA formation coupled with the low TOC, 371 
UV254 absorbance, and total fluorescence values (Table S12) indicate that the NDMA precursors 372 
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may have been removed by the PAC-supplemented biological treatment process. With respect to 373 
the BAC process, the persistence of NMEA suggests it might be more biologically recalcitrant 374 
than NDMA.   375 
3.4 Full-Scale Site D (GA, USA) 376 
 The treatment train at Site D includes primary clarifiers; activated sludge (SRT = 10-12 377 
days) with nitrification, denitrification, and biological phosphorus removal; secondary clarifiers; 378 
lime addition; recarbonation; parallel ultrafiltration and dual media filtration systems; pre-379 
ozonation (O3/DOC = 0.2-0.3), BAC (EBCT = 15 min), and post-ozonation (O3/TOC = 0.2-0.4). 380 
Detailed descriptions of the treatment train, sampling locations, and general water quality are 381 
provided in Text S4 in the SI. 382 
 NDMA was the only nitrosamine detected at Site D. The concentration in the primary 383 
effluent was 42 ng/L, but the concentration dropped to 6.8 ng/L after secondary treatment, which 384 
is consistent with the relatively long SRT and the observed EfOM transformation (i.e., 69% 385 
reduction in UV254 absorbance and 79% reduction in total fluorescence). However, the NDMA 386 
concentration subsequently increased to 9.2 ng/L during ozonation. In comparison to the ~120% 387 
increase at Site A, the smaller 56% increase might be attributable to the relatively low O3/DOC 388 
ratio of 0.2-0.3. The downstream BAC process reduced the NDMA concentration to <MRL and 389 
presumably removed NDMA precursors as well since the final ozonation step did not yield 390 
quantifiable NDMA. Therefore, no nitrosamines were detected in the finished effluent, which is 391 
discharged to a nearby surface water for potable reuse applications.  392 
3.5 Full-Scale Site E (GA, USA) 393 
 Site E is primarily an industrial wastewater treatment facility that receives denim mill 394 
discharge with a pH of 10.5-11. The facility includes preliminary treatment with aeration and pH 395 
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adjustment, extended aeration (SRT = N/A), polymer addition, clarification, and ozonation 396 
(O3/DOC = 1.0-1.2). Preliminary effluent, clarifier effluent, and ozone effluent were collected 397 
for analysis. Detailed descriptions of the treatment train, sampling locations, and general water 398 
quality are provided in Text S5 in the SI. 399 
 The EfOM in all samples was highly concentrated (i.e., high DOC concentrations) and 400 
complex (i.e., significant aromaticity and fluorophore concentrations). NDMA was detected in 401 
the primary effluent at a relatively high level of 89 ng/L, and the concentration only decreased by 402 
19% to 72 ng/L during biological treatment. This is consistent with the relatively poor quality of 403 
the clarifier effluent, which still contained 25 mg/L of DOC, a UV254 absorbance of 0.376 cm-1, 404 
and a total fluorescence of 133,133 AFU. Despite the high ozone dose (O3 = 28-32 mg/L; 405 
O3/DOC = 1.0-1.2), the UV254 absorbance and total fluorescence only decreased by 26% and 406 
58%, respectively. This level of transformation is typically associated with an O3/TOC or 407 
O3/DOC of 0.25 in secondary effluent (Gerrity et al., 2012), which reflects the complex nature of 408 
this particular matrix. Despite the high EfOM concentration and complexity, the NDMA 409 
increased by only 18% from 72 ng/L to 85 ng/L. In addition, this was the only site where NDEA 410 
was detected; the concentrations were 20 ng/L and 19 ng/L in the clarifier effluent and ozone 411 
effluent, respectively. Therefore, the finished effluent, which is discharged to a nearby surface 412 
water, contained 85 ng/L of NDMA and 19 ng/L of NDEA. 413 
3.6 Full-Scale Site F (QLD, AUS) 414 
Site F is an advanced treatment facility that receives nitrified secondary effluent (SRT = 415 
16 days) from a nearby wastewater treatment plant. The advanced treatment train includes 416 
denitrification with methanol addition, pre-ozonation (O3 = 2 mg/L; O3/DOC = 0.2), alum and 417 
polymer addition, dissolved air flotation, sand filtration, ozonation (O3 = 5 mg/L; O3/TOC = 0.6-418 
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0.8), BAC (EBCT = 18 min), and post-ozonation (O3 = 2 mg/L; O3/TOC = 0.5) for final 419 
disinfection (Reungoat et al., 2010; Reungoat et al., 2012). Primary effluent, secondary effluent, 420 
denitrification effluent, pre-ozone effluent, flotation/filtration effluent, ozone effluent, BAC 421 
effluent, and post-ozone effluent samples were collected for analysis. Detailed descriptions of the 422 
treatment train, sampling locations, and general water quality are provided in Text S6 in the SI. 423 
The primary effluent from this facility appeared to be relatively complex based on its 424 
high total fluorescence value, although it did not contain any quantifiable nitrosamines. The 425 
subsequent reductions in UV254 absorbance and total fluorescence were consistent with the 426 
biological treatment and ozonation employed at this facility. NDMA was first detected in the 427 
pre-ozone effluent at a concentration of 5.4 ng/L. The NDMA remained stable through the sand 428 
filters but then increased again to 11 ng/L in the main ozone effluent, thereby indicating that the 429 
NDMA precursors had not been consumed by the relatively low pre-ozone dose (O3/DOC = 0.2). 430 
Similar to Site E, the NDMA was <MRL after BAC and the post-ozone step. Therefore, all of the 431 
nitrosamines were <MRL in the finished effluent, which is discharged to a nearby surface water.  432 
3.7 Full-Scale Site G (CA, USA) 433 
Site G is a full advanced treatment facility that receives nitrified/denitrified secondary 434 
effluent (SRT = 5.5 days) from a nearby wastewater treatment plant. The solids handling 435 
processes at the wastewater treatment plant include anaerobic digesters and belt filter presses. 436 
The digester supernatant and filtrate are returned upstream of the primary clarifiers for repeated 437 
treatment. Polymer is also added at the headworks, primary clarifiers, and belt filter presses. The 438 
advanced treatment train includes MF with chloramine addition, RO, UV/H2O2, and product 439 
water stabilization prior to discharge to spreading grounds or direct injection into the local 440 
aquifer. MF influent (post-chloramine), MF effluent, RO permeate, RO concentrate, and 441 
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UV/H2O2 effluent were collected for this study. Detailed descriptions of the treatment train, 442 
sampling locations, and general water quality are provided in Text S7 in the SI. 443 
 Since chloramination is commonly associated with NDMA formation, data from Site G 444 
were included in this study as a basis for comparison with the ozone-based treatment trains. 445 
Presumably due to chloramination (or possibly combined with background levels), NDMA was 446 
detected at 16 ng/L in the MF influent; NMOR was also detected at 6.9 ng/L. Additional 447 
chloramine exposure led to an increase in NDMA to 42 ng/L and a NMOR concentration of 7.5 448 
ng/L in the MF effluent. RO reduced the NMOR concentration to <MRL and provided a 52% 449 
decrease in NDMA, which is consistent with reductions reported in the literature (Plumlee et al., 450 
2008). After UV/H2O2, the final concentrations of all nitrosamines were <MRL. However, the 451 
RO concentrate contained 100 ng/L of NDMA and 18 ng/L of NMOR. 452 
3.8 Pilot-Scale Site H (CA, USA) 453 
 Prior to its recent expansion and upgrade, the full advanced treatment facility at Site H 454 
was identical to that of Site G. However, Site H receives non-nitrified secondary effluent (pure 455 
oxygen; SRT = 1.5 days), which leads to significant organic fouling of the membranes. To 456 
mitigate this issue, Site H recently installed an ozone system upstream of its MF membranes, and 457 
they also piloted parallel treatment trains to quantify the net benefits of preozonation on 458 
membrane fouling. For this study, samples were collected from the pilot-scale treatment trains 459 
composed of MF-RO and ozone-MF-RO; both trains also included sodium hypochlorite addition, 460 
which reacted with ambient ammonia to form chloramine immediately upstream of the MF 461 
membranes. The O3/TOC ratios were varied from 0.3-1.5 throughout the six-month test period 462 
(from late April 2011 to early November 2011) to evaluate the impact of ozone dose on NDMA 463 
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formation; the other nitrosamines were not monitored at Site H. Detailed descriptions of the 464 
treatment train, sampling locations, and general water quality are provided in Text S8 in the SI. 465 
 Figure 3 illustrates the range of NDMA concentrations observed over the test period in 466 
both trains. The NDMA concentrations in the control train (i.e., MF-RO) are consistent with 467 
those from Site G. However, the extremely high level of ozone-induced NDMA formation in the 468 
experimental train, which ranged from 30 ng/L to 143 ng/L, is the most significant observation. 469 
Although it is significantly higher than other sites in this study, similar levels of ozone-induced 470 
NDMA formation have been reported previously (Kosaka et al., 2009; Gerrity et al., 2014). The 471 
data for the control versus the experimental train suggests that ozone-induced NDMA formation 472 
is more problematic than chloramine-induced NDMA formation for this site, assuming typical 473 
oxidant dosing conditions. Additional studies are needed to determine whether the difference in 474 
formation is due to differing precursors or kinetics.  475 
The reason(s) for this high level of NDMA formation are not entirely clear. The primary 476 
distinction between this facility and the other sites in this study is that Site H ozonates non-477 
nitrified secondary effluent that receives limited biological pretreatment (i.e., SRT = 1.5 days) 478 
with variable efficacy (i.e., total fluorescence ranges from 123,057 AFU to 239,104 AFU in the 479 
secondary effluent). Other facilities employ anaerobic digesters and polymer addition without 480 
substantial increases in NDMA, but their more extensive biological pretreatment might be 481 
sufficient to mitigate potential precursors in the return flows. However, the site from Gerrity et al. 482 
(2014) that exhibited high direct nitrosamine formation (i.e., up to 125 ng/L of NDMA in 483 
addition to low levels of NMEA, NDEA, and NDBA) employed extensive biological 484 
pretreatment with an SRT of 12 days, nitrification, and partial denitrification. Therefore, the 485 
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extent of biological pretreatment is not an absolute indicator of ozone-induced nitrosamine 486 
formation potential. 487 
 As indicated by the box-and-whisker plots in Figure 3, there was significant temporal 488 
variability in the NDMA concentrations over the study period. Figure 4 illustrates the temporal 489 
variability in the secondary effluent and ozonated secondary effluent in relation to the 490 
corresponding sample dates. Data analyses were performed to evaluate whether EfOM 491 
characteristics (Table S28, Figure S17, and Figure S18), secondary effluent NDMA 492 
concentrations (Figure S19), or O3/TOC ratios (Figure 5) could be used to predict ozone-induced 493 
NDMA formation. Similar to the O3/TOC data in Figure 5, none of these parameters exhibited a 494 
correlation with NDMA formation. This indicates that more specific precursor compounds that 495 
also exhibit temporal variability may be responsible for the high levels of NDMA formation at 496 
certain facilities (Hollender et al., 2009). The full-scale version of Site H relies on RO and the 497 
photolysis component of its UV/H2O2 process to achieve the 10-ng/L notification level 498 
established by CDPH for NDMA.  499 
3.9 Full-Scale Site I (NV, USA) and Full-Scale Site J1 (NV, USA) 500 
Sites I and J1 were included in the study as a basis for comparison with the 501 
aforementioned ozone-based treatment trains. They are grouped together due to their similar 502 
treatment trains, water quality, and geographic location. Both treatment trains include primary 503 
clarifiers; activated sludge (SRT = 6-8 days) with nitrification, denitrification, and biological 504 
phosphorus removal; secondary clarifiers, and media filtration. Site I includes an advanced 505 
treatment train with flocculation, tertiary clarifiers, and UV disinfection or sodium hypochlorite 506 
addition, depending on the discharge mechanism (i.e., surface water and a reclaimed water 507 
distribution system, respectively). Site J1 uses only sodium hypochlorite addition for final 508 
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disinfection. Detailed descriptions of the treatment trains, sampling locations, and general water 509 
quality are provided in Text S9 and Text S10 in the SI. 510 
Unlike the facilities with ozonation or chloramination, there was no observable change in 511 
nitrosamine concentrations after chlorination or UV treatment at Sites I and J1. This is consistent 512 
with the literature on NDMA formation with various oxidants (Lee et al., 2007; Mitch and 513 
Sedlak, 2002; Nawrocki and Andrzejewski, 2011; Pehlivanoglu-Mantas et al., 2008). In fact, 514 
only NMOR (11 ng/L) was detected in the secondary effluent at both sites; NMOR was also 515 
present in the filter effluent (13 ng/L) and chlorinated effluent (11 ng/L) at Site I. If nitrosamines 516 
had been present at higher concentrations, the relatively low UV dose used for disinfection at 517 
Site I (<100 mJ/cm2) would have achieved minimal reductions compared to the UV/H2O2 518 
systems at the full advanced treatment facilities (>100 mJ/cm2). 519 
3.10 Pilot-Scale Site J2 (NV, USA) 520 
 Similar to the pilot system at Site H, the primary objective of Site J2 was to quantify the 521 
net benefits of preozonation on membrane fouling, specifically RO membranes; the results have 522 
been published previously (Stanford et al., 2011; Pisarenko et al., 2011; 2012; 2014). Site J2 523 
treats primary effluent from full-scale Site J1 with a pilot-scale MBR and parallel trains 524 
composed of RO and ozone-RO. Detailed descriptions of the treatment trains, pilot-scale 525 
reactors, sampling locations, and general water quality are provided in Text S11 in the SI. 526 
For the current study, nitrosamine concentrations were monitored in the MBR filtrate and 527 
the ozone effluent, and the MBR was operated in multiple modes (i.e., BOD removal with SRT = 528 
2.4 days vs. nitrification/denitrification with SRT = 18.8 days) to evaluate the impacts of varying 529 
biological pretreatment on downstream NDMA formation during ozonation. After the MBR had 530 
stabilized in each operational mode, the O3/DOC ratios were varied from 0.2-1.0. It is important 531 
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to note that the two MBR modes were sampled several months apart so observed differences in 532 
NDMA may be a result of temporal variability of precursor concentrations and/or operational 533 
differences.  534 
NDMA and NMOR were the only nitrosamines >MRL at Site J2, and NMOR was only 535 
reportable in one sample at 11 ng/L, which is just above the corresponding MRL of 10 ng/L 536 
(Table S40). Figure 6 illustrates the ozone-induced formation of NDMA in the MBR filtrate as a 537 
function of O3/DOC ratio. Figure 6 indicates that direct NDMA formation may be a function of 538 
ozone dose at O3/DOC ratios <0.5, but NDMA formation appears to plateau at O3/DOC ratios 539 
>0.5. This relationship with ozone dose was not observed at Site H presumably because of the 540 
more variable water quality of the non-nitrified secondary effluent (Table S28 and Figure S17). 541 
Furthermore, Figure 6 indicates that extensive biological pretreatment (e.g., nutrient removal 542 
with higher SRTs) may lead to reduced NDMA formation during ozonation. The higher NDMA 543 
levels in the non-nitrified ozone effluent from Site J2 coupled with the extremely high values in 544 
the non-nitrified ozone effluent from Site H indicate that nitrification/denitrification may be a 545 
viable mitigation strategy. However, systems with extensive biological pretreatment, including 546 
nitrification and denitrification, may still observe exceedingly high levels of NDMA formation 547 
during ozonation (Gerrity et al., 2014), presumably due to the presence of precursors with high 548 
yields and/or concentrations. 549 
 550 
4.0 Conclusion 551 
 Nitrosamine formation during ozonation poses a challenge for municipalities seeking to 552 
avoid RO and high-dose UV in potable reuse systems. There is limited occurrence data available, 553 
particularly for the less common nitrosamines, and the precursors and reaction pathways are not 554 
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completely understood. This study indicated that NDMA and NMOR are the most prevalent 555 
nitrosamines in untreated and treated wastewater. NMEA and NDEA were also detected at two 556 
facilities, although one of those facilities receives primarily industrial wastewater. NDPrA and 557 
NDBA were <MRL in all samples.  558 
 NDMA and NMOR were present at concentrations as high as 89 ng/L in the primary 559 
effluent at some facilities, but biological treatment achieving full nitrification (i.e., high SRTs) 560 
proved to be a relatively effective mitigation measure for these nitrosamines. In the facilities 561 
with ozonation, all but one exhibited NDMA formation during ozonation, although the 562 
concentrations were generally low for facilities receiving primarily domestic wastewater and 563 
employing effective biological pretreatment. However, one facility exhibited NDMA formation 564 
exceeding 100 ng/L. The reasons for this anomaly are not entirely clear so additional research 565 
into specific precursors and formation pathways is warranted. The other nitrosamines appeared 566 
to be unaffected by ozonation. Downstream BAC was also effective in reducing NDMA 567 
concentrations to <MRL and eliminating precursors that might form NDMA during final 568 
disinfection. As expected, the combination of RO and high-dose UV (i.e., UV/H2O2) was also 569 
effective in achieving the MRL for all nitrosamines, although significant concentrations were 570 
present in the RO concentrate.  571 
 Therefore, NDMA formation is a potential concern for ozone-based potable reuse 572 
treatment trains, but the formation is generally low and can be mitigated with established 573 
technologies that would likely be included in those treatment trains regardless of NDMA 574 
concerns. However, this issue is a significant concern for certain systems that experience 575 
unusually high levels of NDMA formation. Additional research is needed to identify the sources 576 
and identities of the precursors at these sites. 577 
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Table 1. Description of treatment trains and operational conditions at study sites  
Site Location Flow  
(106 m3/d) 
2° Treatmenta SRT 
(days) 
3° Treatmenta O3/DOC or 
O3/TOC 
Sampling Date 
(MM/DD/YYYY) 
A MO, USA 1.14 CAS; N+BPR+DN 18-20 GF-O3 1.0-1.2 10/10/2011; 05/01/2012 
B KY, USA 0.37 OD; N+DN N/A O3 0.9 03/06/2012 
C TX, USA 0.45 CAS+PAC; N+DN 10; 36 Lime-GF-O3-BAC 0.3 10/31/2012 
D  GA, USA 1.61 CAS; N+DN+BPR 11 Lime-GF/UF-O3-BAC-O3 0.2-0.3; 0.2-0.3 02/01/2012 
E  GA, USA 0.21 CAS; N N/A O3 1.0-1.2 04/16/2012 
F QLD, AUS 0.08 CAS; N 16 DN-O3-GF-O3-BAC-O3 0.2; 0.6-0.8; 0.5 05/15/2012 
G CA, USA 2.65 TF+CAS; N+DN 5.5 MF-RO-UV/H2O2 N/Ac 10/10/2011 
H CA, USA Pilotb CAS 1.5 O3-MF-RO; MF-RO 0.3-1.5 N/Ac 
I NV, USA 3.79 CAS; N+DN+BPR 7 GF-UV; GF-NaOCl N/Ac 03/28/2012 
J1  NV, USA 2.84 TF/CAS; N+DN+BPR 6-8 GF-NaOCl N/Ac 03/28/2012 
J2  NV, USA Pilotb MBR; Multiple Modes 2-19c O3-RO; RO 0.0-1.0 N/Ac 
a
 CAS = conventional activated sludge, MBR = membrane bioreactor, OD = oxidation ditch, TF = trickling filter, N = nitrification, 
DN = denitrification, BPR = biological phosphorus removal, GF = gravity filtration, BAC = biological activated carbon, PAC = 
powdered activated carbon, MF = microfiltration, UF = ultrafiltration, RO = reverse osmosis 
b
 Both pilot-scale treatment trains operated at 121 m3/day. 
c
 N/A = not available or applicable 
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Figure 1.  Comparison of NDMA concentrations in the primary, secondary, ozone (initial 
ozonation step only), and BAC effluents from the full-scale and pilot-scale sites. Arrows 
indicate concentrations less than the corresponding method reporting limit. The data for 
Site A are based on the results from the second sampling event. Site G was omitted 
because the secondary effluent sample was influenced by chloramination. The data for 
pilot-scale Site H are based on averages over the sampling period, and error bars 
represent ±1 standard deviation. The data for pilot-scale site J2 are based on O3/DOC = 
0.5 in the BOD removal mode.  
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Figure 2.  Comparison of NMOR concentrations in the primary, secondary, ozone (initial 
ozonation step only), and BAC effluents from the full-scale sites. Arrows indicate 
concentrations less than the corresponding method reporting limit. The data for Site A are 
based on the results from the second sampling event. Site G was omitted because all of 
the samples were influenced by chloramination.  
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Figure 3.  Summary of NDMA concentrations at Site H (CA) (late April 2011 to early 
November 2011). Dots correspond to median values, boxes correspond to inner quartiles, 
and whiskers correspond to minimum and maximum values.    
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Figure 4.  Temporal variability of the NDMA concentrations in the ozonated secondary 
effluent and non-ozonated secondary effluent at Site H (CA). These data represent 
samples collected weekly from late April 2011 to early November 2011. 
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Figure 5.  NDMA formation as a function of O3/TOC ratio at Site H (CA). These data 
represent samples collected weekly from late April 2011 through early November 2011.   
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Figure 6.  NDMA formation as a function of solids retention time during biological 
pretreatment and O3/DOC ratio in the Site J2 pilot. Error bars indicate the minimum and 
maximum concentrations from duplicate samples.  
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• NDMA and NMOR were the most prevalent nitrosamines at the 11 study sites 
• NMEA and NDEA were detected at one facility each; NDPrA and NDBA were 
always <MRL   
• Ozone-induced NDMA formation ranged from <10 to 143 ng/L 
• Ozone-induced NDMA formation was lower in nitrified wastewater and at 
O3/DOC <0.5 
• Biodegradation was effective for NDMA and NMOR mitigation 
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List of Abbreviations 
AFU  Arbitrary fluorescence units 
AOP  Advanced oxidation process 
ASPE  Automated solid phase extraction 
BAC  Biological activated carbon 
BOD  Biochemical oxygen demand 
CA  California 
COD  Chemical oxygen demand 
DCM  Dichloromethane 
DO  Dissolved oxygen 
DOC  Dissolved organic carbon 
EBCT  Empty bed contact time 
EEM  Excitation emission matrix 
EfOM  Effluent organic matter 
EPA  Environmental Protection Agency 
GA  Georgia 
KY  Kentucky 
MBR  Membrane bioreactor 
MDL  Method detection limit 
MF  Microfiltration 
MGD  Million gallons per day 
MO  Missouri 
MRL  Method reporting limit 
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MRM  Multiple reaction monitoring 
N/A  Not available or not applicable 
NDBA  N-nitrosodibutylamine 
NDEA  N-nitrosodiethylamine 
NDMA N-nitrosodimethylamine 
NDPhA N-nitrosodiphenylamine 
NDPrA N-nitrosodipropylamine 
NMEA N-nitrosomethylethylamine 
NMOR N-nitrosomorpholine 
NPIP  N-nitrosopiperidine 
NPYR  N-nitrosopyrrolidine 
NTU  Nephelometric turbidity units 
NV  Nevada 
PAC  Powdered activated carbon 
QLD  Queensland 
RO  Reverse osmosis 
RSD  Relative standard deviation 
SRT  Solids retention time 
SUVA  Specific UV254 absorbance 
TF  Total fluorescence 
TKN  Total Kjeldahl Nitrogen 
TN  Total nitrogen 
TOC  Total organic carbon 
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TON  Total oxidized nitrogen (i.e., NO2- + NO3-) 
TP  Total phosphorus 
TSS  Total suspended solids 
TX  Texas 
UF  Ultrafiltration 
U.S.  United States 
UV  Ultraviolet 
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Text S1. Full-Scale Site A (MO) 
The average daily flow at Site A (MO) is approximately 30 million gallons per day (mgd). 
During wet weather events, excess flows are bypassed to a 43 million gallon holding tank, while 
peak flows are discharged to nearby surface water after coagulant addition and clarification. 
During normal flow conditions, wastewater is treated with trash racks, bar screens, aerated grit 
chambers, primary clarifiers, and parallel biological treatment systems (i.e., Train #1 and Train 
#2). Train #1 includes alum addition for chemical phosphorus removal, oxygenation tanks (solids 
retention time (SRT) = 2-3 days), secondary clarifiers, nitrification tanks (SRT = 30+ days), 
tertiary clarifiers, and denitrifying mixed media filters. Train #2 includes conventional activated 
sludge (SRT = 18-20 days) with nitrification and biological phosphorus removal, alum addition 
for chemical phosphorus removal, secondary clarifiers, and sand filters. The parallel flows then 
recombine prior to ozone disinfection at an average dose of 6 mg/L, which corresponds to an 
ozone to dissolved organic carbon (O3/DOC) ratio of approximately 1.0-1.2. The finished 
effluent is discharged to a nearby surface water. The facility also includes solids handling 
processes, including anaerobic digesters and dewatering centrifuges with polymer addition. 
Centrate and digester supernatant are combined with primary effluent for repeated biological 
treatment. Any residual polymer in the return flow is expected to be degraded biologically, and 
no additional polymer is used in the clarifiers prior to ozonation. The treatment train is illustrated 
in Figure S1, and nitrosamine sampling locations are indicated by the colored circles, which are 
defined in Table S1. 
For Site A, preliminary sampling for method development was performed in October 
2011, and a second sampling event was conducted in May 2012. The average water quality for 
the facility is summarized in Table S2. Data characterizing the effluent organic matter (EfOM) 
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for the October 2011 and May 2012 sampling events are summarized in Tables S3 and S4, 
respectively. The nitrosamine summaries for the October 2011 and May 2012 sampling events 
are provided in Tables S5 and S6, respectively. 
Table S1. Sampling locations for Site A (MO) 
Sample Description 
1 Primary Influent 
2 Primary Effluent 
3 Secondary Effluent 
4 Combined Ozone Influent 
5 Ozone Effluent 
6 Field Blank 
 
Figure S1. Treatment train schematic and sampling locations for Site A (MO) 
 
Table S2. Water quality data for Site A (MO) (October 2011) 
Parameter Primary 
Influent 
Primary 
Effluent 
Secondary 
Effluent 
(Plant 2) 
Combined 
Ozone 
Influent 
Ozone 
Effluent 
TKN (mg/L) 34.1 N/A N/A N/A < 0.03 
NH3 (mg-N/L) 20.4 20.9 < 0.1 N/A < 0.1 
TN (mg/L) N/A 25 10 11 12 
BOD (mg/L) N/A N/A N/A N/A 3 
TSS (mg/L) 284 200 4 N/A < 1 
pH 7.28 7.48 7.67 N/A 7.87 
TP (mg/L) 3.75 N/A N/A N/A 0.45 
*N/A = Not Available  
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Table S3. EfOM Characterization Data for Site A (MO) (October 2011) 
Parameter Primary 
Influent 
Primary 
Effluent 
Secondary 
Effluent 
(Plant 2) 
Combined 
Ozone 
Influent 
Ozone 
Effluent 
Field 
Blank 
UV254 (cm-1) N/A 0.201 0.134 0.116 0.059 < 0.002 
UV280 (cm-1) N/A 0.148 0.108 0.091 0.039 < 0.002 
DOC (mg/L) N/A 45 5.7 4.9 N/A N/A 
TOC (mg/L N/A N/A N/A N/A 4.8 < 0.2 
SUVA (L/mg-m) N/A 0.447 2.35 2.37 1.23 N/A 
TN (mg/L) N/A 25 10 11 12 < 0.2 
TF (AFU) N/A 73,516 37,513 28,782 4,546 93 
Region 1 (AFU) N/A 40,786 14,767 10,298 1,269 66 
Region 2 (AFU) N/A 26,081 16,964 13,746 2,398 20 
Region 3 (AFU) N/A 6,649 5,782 4,748 878 7 
*N/A = Not Available 
 
Figure S2. Qualitative comparison of EEMs for Site A (MO) (October 2011) 
 
 
Table S4. EfOM characterization for Site A (MO) (May 2012) 
Parameter Primary 
Influent 
Primary 
Effluent 
Secondary 
Effluent 
(Plant 2) 
Combined 
Ozone 
Influent 
Ozone 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.231 0.210 0.112 0.108 0.066 <0.002 
UV280 (cm-1) 0.172 0.155 0.084 0.081 0.043 < 0.002 
DOC (mg/L) 44 19 6.7 5.8 N/A N/A 
TOC (mg/L) N/A N/A N/A N/A 6.1 0.33 
SUVA (L/mg-cm) 0.525 1.11 1.67 1.86 1.08 N/A 
TN (mg/L) 19 15 9.3 10 11 < 0.2 
TF (AFU) 58,749 53,937 26,185 23,525 5,675 153 
Region 1 (AFU) 34,912 30,184 10,509 8,885 1,920 89 
Region 2 (AFU) 19,098 18,899 11,813 10,962 2,786 48 
Region 3 (AFU) 4,738 4,854 3,862 3,678 969 17 
*N/A = Not Applicable 
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Figure S3. Qualitative comparison of EEMs for Site A (MO) (May 2012) 
 
 
Table S5. Nitrosamines data for Site A (MO) (October 2011) 
Nitrosamine Primary 
Influent 
Primary 
Effluent 
Secondary 
Effluent 
(Plant 2) 
Combined 
Ozone 
Influent 
Ozone 
Effluent 
Field 
Blank 
NDMA (ng/L) N/A < 25 11 12 26 < 2.5 
NMEA (ng/L) N/A < 25 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) N/A < 50 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) N/A < 100 < 20 < 20 < 20 < 10 
NMOR (ng/L) N/A < 50 12 12 < 10 < 5.0 
NDBA (ng/L) N/A < 100 < 20 < 20 < 20 < 10 
*N/A = Not Available 
 
Table S6. Nitrosamines data for Site A (MO) (May 2012) 
Nitrosamine Primary 
Influent 
Primary 
Effluent 
Secondary 
Effluent 
(Plant 2) 
Combined 
Ozone 
Influent 
Ozone 
Effluent 
Field 
Blank 
NDMA (ng/L) < 25 < 25 7.8 6.3 14 < 2.5 
NMEA (ng/L) < 25 < 25 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) < 50 < 50 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 100 < 20 < 20 < 20 < 10 
NMOR (ng/L) 65 58 22 23 22 < 5.0 
NDBA (ng/L) < 100 < 100 < 20 < 20 < 20 < 10 
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Text S2. Full-Scale Site B (KY) 
The average daily flow at Site B (KY) is 9.9 mgd. The treatment train includes grit 
removal, an oxidation ditch with nitrification and partial denitrification (SRT = N/A), 
clarification, and ozone disinfection at an average dose of 3.3 mg/L, which corresponds to an 
ozone to total organic carbon (O3/TOC) ratio of approximately 0.9. The final effluent is 
discharged to a nearby surface water. Solids handling processes include sludge thickening, two-
stage anaerobic digesters, and sludge drying beds. Digester supernatant is returned to the process 
flow prior to biological treatment in the oxidation ditch.  
 
Table S7. Sampling locations for Site B (KY) 
Sample Description 
1 Preliminary Effluent 
2 Clarifier Effluent 
3 Ozone Effluent 
4 Digester Supernatant 
5 Field Blank 
 
 
Figure S4. Treatment train schematic and sampling locations for Site B (KY) 
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Table S8. Water quality data for Site B (KY) (March 2012) 
Parameter Plant Influent Preliminary 
Effluent 
Clarifier 
Effluent 
Ozone 
Effluent 
Digester 
Supernatant 
pH 7.00 N/A N/A 7.68 N/A 
NH3 (mg-N/L) 73 N/A N/A 0.3 N/A 
TN (mg/L) N/A 18 4.0 4.4 14 
TSS (mg/L) 297 N/A N/A 14.8 N/A 
COD (mg/L) 442 N/A N/A 30 N/A 
TP (mg/L) 3.52 N/A N/A 0.52 N/A 
Turbidity (NTU) N/A N/A N/A 3.1 N/A 
*N/A = Not Available 
 
Table S9. EfOM characterization for Site B (KY) (March 2012) 
Parameter Preliminary 
Effluent 
Clarifier 
Effluent 
Ozone 
Effluent 
Digester 
Supernatant 
Field 
Blank 
UV254 (cm-1) 0.195 0.076 0.044 0.767 0.002 
UV280 (cm-1) 0.140 0.057 0.027 0.629 < 0.002 
DOC (mg/L) 25 N/A N/A 30 N/A 
TOC (mg/L) N/A 3.6 3.6 N/A <0.2 
SUVA (L/mg-m) 0.78 2.11 1.22 2.56 N/A 
TN (mg/L) 18 4.0 4.4 14 < 0.2 
TF (AFU) 58,752 18,145 4,031 296,028 51 
Region 1 (AFU) 31,649 4,810 1,105 162,251 16 
Region 2 (AFU) 21,661 9,766 2,123 112,372 28 
Region 3 (AFU) 5,442 3,570 803 21,405 7 
*N/A = Not Applicable 
 
Figure S5. Qualitative comparison of EEMs for Site B (KY) (March 2012) 
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Table S10. Nitrosamines data for Site B (KY) (March 2012) 
Nitrosamine Preliminary 
Effluent 
Clarifier 
Effluent 
Ozone 
Effluent 
Digester 
Supernatant 
Field 
Blank 
NDMA (ng/L) 25 < 5.0 5.2 < 5.0 < 2.5 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 10 
NMOR (ng/L) 67 21 20 13 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 10 
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Text S3. Full-Scale Site C (TX) 
The average daily flow at Site C is approximately 12 mgd. The treatment train includes 
bar screens, grit removal, primary clarifiers, biological treatment with two-stage activated sludge, 
lime clarification (pH = 11), two-stage recarbonation (pH = 9.3 then 7.3), sand filtration, 
ozonation (O3 = 1.0-1.3 mg/L; O3/TOC = 0.3), and biological activated carbon (BAC). The first 
stage of the activated sludge process includes aeration and nitrification (SRT = 10 days), a 
supplemental powdered activated carbon (PAC) feed, and clarification. The second stage 
achieves denitrification (SRT = 36 days) with methanol as the carbon source, and the denitrified 
effluent is clarified again prior to lime addition. The carbon in the BAC process is approximately 
10 years old, and the process is operated with a 16-minute empty bed contact time (EBCT). The 
finished effluent is injected into the local aquifer. Anaerobic digesters are used for processing of 
primary solids.  
 
Table S11. Sampling locations for Site C (TX) 
Sample Description 
1 Primary Effluent 
2 Tertiary Clarifier Effluent 
3 Filter Effluent 
4 Ozone Effluent 
5 BAC Effluent 
6 Field Blank 
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Figure S6. Treatment train schematic and sampling locations for Site C (TX) 
 
 
Table S12. EfOM characterization for Site C (TX) (October 2012) 
Parameter Primary 
Effluent 
Tertiary 
Clarifier 
Effluent 
Sand 
Filter 
Effluent 
Ozone 
Effluent 
BAC 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.277 0.103 0.067 0.040 0.035 < 0.002 
UV280 (cm-1) 0.205 0.080 0.051 0.026 0.024 < 0.002 
DOC (mg/L) 38 3.6 N/A N/A N/A N/A 
TOC (mg/L) N/A N/A 3.6 3.1 2.3 < 0.2 
SUVA (L/mg-m) 0.73 2.86 1.86 1.29 1.52 N/A 
TN (mg/L) 37 2.6 4.5 4.1 4.0 < 0.2 
TF (AFU) 108,758 25,489 17,911 N/A 5,015 18 
Region 1 (AFU) 66,905 9,111 6,851 N/A 1,729 4 
Region 2 (AFU) 33,137 11,842 7,999 N/A 2,415 11 
Region 3 (AFU) 8,716 4,536 3,060 N/A 870 2 
*N/A = Not Applicable 
 
Figure S7. Qualitative comparison of EEMs for Site C (TX) (October 2012) 
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Table S13. Nitrosamines data for Site C (TX) (October 2012) 
Nitrosamine  Primary 
Effluent 
Tertiary 
Clarifier 
Effluent 
Sand 
Filter 
Effluent 
Ozone 
Effluent 
BAC 
Effluent 
Field 
Blank 
NDMA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 5.0 < 2.5 
NMEA (ng/L) < 25 < 5.0 < 5.0 6.3 7.6 < 2.5 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 20 < 10 
NMOR (ng/L) < 50 < 10 < 10 < 10 < 10 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 20 < 10 
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Text S4. Full-Scale Site D (GA) 
The average daily flow at Site D is 42.5 mgd. The treatment train includes bar screens; 
grit removal; primary clarifiers; activated sludge (SRT = 11 days) with nitrification, 
denitrification, and biological phosphorus removal; secondary clarifiers, and lime clarification. 
The flow is then split between the original train, which employs recarbonation and dual-media 
filtration, and the new train with strainers and ultrafiltration (UF) membranes. The water 
recombines for pre-ozonation (O3 = 1.0-1.5 mg/L; O3/DOC = 0.2-0.3), BAC, and post-ozonation 
(O3 = 1.0-1.5 mg/L; O3/TOC = 0.2-0.4). The BAC process is operated with a 15-minute EBCT, 
and the carbon is approximately 6-8 years old. The final effluent is discharged to a nearby 
surface water. The facility also employs anaerobic digesters and dewatering centrifuges. 
 
Table S14. Sampling locations for Site D (GA) 
Sample Description 
1 Primary Effluent 
2 Secondary Effluent 
3 Pre-ozone Influent 
4 Pre-ozone Effluent 
5 BAC Effluent 
6 Post-ozone Effluent 
7 Field Blank 
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Figure S8. Treatment train schematic and sampling locations for Site D (GA) 
 
 
Table S15. EfOM characterization for Site D (GA) (February 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Pre-
ozone 
Influent 
Pre-
ozone 
Effluent 
BAC 
Effluent 
Post-
ozone 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.372 0.115 0.107 0.082 0.070 0.047 < 0.002 
UV280 (cm-1) 0.282 0.092 0.084 0.061 0.052 0.032 < 0.002 
DOC (mg/L) 42 5.3 5.0 N/A N/A N/A N/A 
TOC (mg/L) N/A N/A N/A 5.0 4.1 3.8 < 0.2 
SUVA (L/mg-m) 0.886 2.17 2.14 1.64 1.75 1.24 N/A 
TN (mg/L) 44 16 15 15 15 15 < 0.2 
TF (AFU) 150,942 32,412 30,324 14,356 11,957 3,931 47 
Region 1 (AFU) 94,084 11,351 10,590 5,052 4,333 1,436 21 
Region 2 (AFU) 46,139 15,133 14,200 6,626 5,420 1,769 18 
Region 3 (AFU) 10,719 5,928 5,533 2,678 2,204 725 7 
*N/A = Not Applicable 
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Figure S9. Qualitative comparison of EEMs for Site D (GA) (February 2012) 
 
 
 
Table S16. Nitrosamines data for Site D (GA) (February 2012) 
Nitrosamine Primary 
Effluent 
Secondary 
Effluent 
Pre-
ozone 
Influent 
Pre-
ozone 
Effluent 
BAC 
Effluent 
Post-
ozone 
Effluent 
Field 
Blank 
NDMA (ng/L) 42 6.8 5.9 9.2 < 5.0 < 5.0 < 5.0 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 10 < 10 < 10 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 20 < 20 < 20 
NMOR (ng/L) < 50 < 10 < 10 < 10 < 10 < 10 < 10 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 20 < 20 < 20 
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Text S5. Full-Scale Site E (GA) 
The average daily flow at this site is 5.5 mgd, and a large fraction of the incoming 
wastewater is industrial discharge from a denim mill with a pH of 10.5-11. The treatment train 
includes preliminary treatment with aeration and pH adjustment to 7.8-8.0 with sulfuric acid, 
biological treatment with extended aeration (SRT = N/A), polymer addition, clarification, and 
ozonation (O3 = 28-32 mg/L; O3/DOC = 1.0-1.2) for color removal and disinfection. The 
finished effluent is discharged to a nearby surface water. 
 
Table S17. Sampling locations for Site E (GA) 
Sample Description 
1 Preliminary Effluent 
2 Clarifier Effluent 
3 Ozone Effluent 
4 Field Blank 
 
 
Figure S10. Treatment train schematic and sampling locations for Site E (GA) 
 
 
Table S18. Water quality data for Site E (GA) (April 2012) 
Parameter Preliminary Effluent Ozone Effluent 
BOD (mg/L) 311 7.54 
TSS (mg/L) 660 6 
PO4 (mg-P/L) N/A 2.81 
TP (mg/L) N/A 9.56 
NH3 (mg-N/L) N/A 0.14 
TN (mg/L) 47 21 
pH N/A 7.53 
DO (mg/L) N/A 16.25 
*N/A = Not Available or Applicable 
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Table S19. EfOM characterization for Site E (GA) (April 2012) 
Parameter Preliminary 
Effluent 
Clarifier 
Effluent 
Ozone 
Effluent 
Field 
Blank 
UV254 (cm-1) 1.35 0.376 0.278 < 0.002 
UV280 (cm-1) 0.989 0.313 0.208 < 0.002 
DOC (mg/L) 120 25 28 N/A 
TOC (mg/L) N/A N/A N/A < 0.2 
SUVA (L/mg-m) 1.13 1.50 0.99 N/A 
TN (mg/L) 47 23 21 < 0.2 
TF (AFU) 721,172 133,133 56,241 12 
Region 1 (AFU) 372,194 51,937 27,015 9 
Region 2 (AFU) 306,663 64,438 22,139 3 
Region 3 (AFU) 42,314 16,758 7,087 0 
*N/A = Not Applicable 
 
Figure S11. Qualitative comparison of EEMs for Site D (GA) (April 2012) 
 
 
 
 
Table S20. Nitrosamines data for Site E (GA) (April 2012) 
Nitrosamine Preliminary 
Effluent 
Clarifier 
Effluent 
Ozone 
Effluent 
Field 
Blank 
NDMA (ng/L) 89 72 85 < 2.5 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 2.5 
NDEA (ng/L)  < 50 20 19 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 10 
NMOR (ng/L) < 50 < 10 < 10 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 10 
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Text S6. Full-Scale Site F (QLD) 
Site F (QLD) is an advanced treatment facility that receives approximately 2 mgd of 
nitrified secondary effluent (SRT = 16 days) from a nearby wastewater treatment plant. The 
advanced treatment train includes denitrification with methanol addition, pre-ozonation (O3 = 2 
mg/L; O3/DOC = 0.2), alum and polymer addition, dissolved air flotation, sand filtration, 
ozonation (O3 = 5 mg/L; O3/TOC = 0.6-0.8), BAC (EBCT = 18 min), and post-ozonation (O3 = 2 
mg/L; O3/TOC = 0.5) for final disinfection (Reungoat et al., 2010; Reungoat et al., 2012). The 
finished effluent is discharged to a nearby surface water.  
 
Table S21. Sampling locations for Site F (QLD) 
 
 
 
 
 
 
Figure S12. Treatment train schematic and sampling locations for Site F (QLD) 
 
Sample Description 
1 Primary Effluent 
2 Secondary Effluent 
3 Denitrification Effluent 
4 Pre-Ozone Effluent 
5 Flotation/Filtration Effluent 
6 Ozone Effluent 
7 BAC Effluent 
8 Post-Ozone Effluent 
9 Field Blank 
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Table S22. EfOM characterization for Site F (QLD) (May 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Denit. 
Effluent 
Pre-
ozone 
Effluent 
Filter 
Effluent 
Ozone 
Effluent 
BAC 
Effluent 
Post-
ozone 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.587 0.221 0.214 0.204 0.131 0.088 0.059 0.046 < 0.002 
UV280 (cm-1) 0.463 0.170 0.162 0.155 0.099 0.061 0.042 0.030 < 0.002 
DOC (mg/L) 100 10 9.5 N/A N/A N/A N/A N/A N/A 
TOC (mg/L) N/A N/A N/A 9.8 6.6 6.0 4.1 4.0 < 0.2 
SUVA (L/mg-m) 0.587 2.21 2.25 2.08 1.98 1.47 1.44 1.15 N/A 
TN (mg/L) 46 9.5 3.6 3.7 4.0 4.2 4.1 4.2 < 0.2 
TF (AFU) 390,541 74,079 74,931 N/A 44,981 18,658 7,735 3,599 226 
Region 1 (AFU) 195,545 25,173 26,795 N/A 16,225 7,190 2,629 1,229 145 
Region 2 (AFU) 160,613 35,996 35,272 N/A 20,127 8,179 3,597 1,679 67 
Region 3 (AFU) 35,383 12,910 12,864 N/A 8,630 3,289 1,508 691 14 
*N/A = Not Available or Applicable 
 
Figure S13. Qualitative comparison of EEMs for Site F (QLD) (May 2012) 
 
 
 
Table S23. Nitrosamines data for Site F (QLD) (May 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Denit. 
Effluent 
Pre-
ozone 
Effluent 
Filter 
Effluent 
Ozone 
Effluent 
BAC 
Effluent 
Post-
ozone 
Effluent 
Field 
Blank 
NDMA (ng/L) < 25 < 5.0 < 5.0 5.4 5.2 11 < 5.0 < 5.0 < 25 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 20 < 20 < 20 < 20 < 10 
NMOR (ng/L) < 50 < 10 < 10 < 10 < 10 < 10 < 10 < 10 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 20 < 20 < 20 < 20 < 10 
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Text S7. Full-Scale Site G (CA) 
The average daily flow at Site G is 70 mgd, but it is currently being expanded to 
accommodate a total flow of 100 mgd. This facility receives nitrified/denitrified secondary 
effluent (combination of trickling filters and activated sludge; SRT = 5.5 days) from a nearby 
wastewater treatment plant and provides advanced treatment with microfiltration (MF), reverse 
osmosis (RO), an advanced oxidation process (AOP) consisting of ultraviolet irradiation and 
hydrogen peroxide (UV/H2O2), and product water stabilization. The finished effluent from Site G 
is either discharged to spreading basins or directly injected into the groundwater aquifer. The 
solids handling processes at the wastewater treatment plant include anaerobic digesters and belt 
filter presses, although the belt filter presses will soon be replaced with dewatering centrifuges. 
The digester supernatant and filtrate (soon to be centrate) are returned upstream of the primary 
clarifiers for repeated treatment. Polymer is also added at the headworks, primary clarifiers, and 
belt filter presses. With respect to this study, the MF influent had been dosed with chloramine 
upstream of the sampling location so the corresponding nitrosamine concentrations may be a 
combination of ambient levels and subsequent formation.  
 
Table S24. Sampling locations for Site G (CA) 
Sample Description 
1 MF Influent 
2 MF Effluent 
3 RO Permeate 
4 RO Concentrate 
5 UV/H2O2 Effluent 
6 Field Blank 
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Figure 14. Treatment train schematic and sampling locations for Site G (CA)  
 
Table S25. EfOM characterization for Site G (CA) (October 2011) 
Parameter MF 
Influent 
MF 
Effluent 
RO 
Permeate 
RO 
Concentrate 
UV/H2O2 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.153 0.125 0.007 0.696 0.004 < 0.002 
UV280 (cm-1) 0.112 0.087 0.004 0.501 < 0.002 < 0.002 
DOC (mg/L) 6.4 N/A N/A N/A N/A N/A 
TOC (mg/L) N/A 6.0 < 0.2 33 < 0.2 < 0.2 
SUVA (L/mg-m) 2.39 2.08 N/A 2.11 N/A N/A 
TN (mg/L) 11 11 1.1 61 1.2 < 0.2 
TF (AFU) 33,466 28,739 46 275,877 40 22 
Region 1 (AFU) 12,729 9,941 9 100,027 5 4 
Region 2 (AFU) 15,310 13,562 40 143,646 33 15 
Region 3 (AFU) 5,427 5,236 51 32,204 2 3 
*N/A = Not Applicable 
 
Figure S15. Qualitative comparison of EEMs for Site G (CA) (October 2011) 
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Table S26. Nitrosamines data for Site G (CA) (October 2011) 
Nitrosamine MF 
Influent 
MF 
Effluent 
RO 
Permeate 
RO 
Concentrate 
UV/H2O2 
Effluent 
Field 
Blank 
NDMA (ng/L) 16 42 20 100 < 2.5 < 2.5 
NMEA (ng/L) < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 
NDEA (ng/L) < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 
NDPrA (ng/L) < 10 < 10 < 10 < 10 < 10 < 10 
NMOR (ng/L) 6.9 7.5 < 5.0 18 < 5.0 < 5.0 
NDBA (ng/L) < 10 < 10 < 10 < 10 < 10 < 10 
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Text S8. Pilot-Scale Site H (CA) 
The average daily flow at Site H is approximately 30 mgd, but only 12.5 mgd is treated 
with full advanced treatment (i.e., RO-UV/H2O2). The advanced treatment facility receives non-
nitrified secondary effluent (pure oxygen; SRT = 1.5 days) from a nearby wastewater treatment 
plant. Due to the limited upstream biological treatment, Site H recently upgraded its facility with 
ozonation to mitigate organic fouling on the MF membranes. The advanced treatment facility 
now includes ozone, MF, RO, UV/H2O2, and product water stabilization prior to direct injection 
of the finished effluent into the groundwater aquifer. Figure S16 illustrates the original and 
upgraded full-scale treatment trains. The solids handling processes at the wastewater treatment 
plant include anaerobic digesters and dewatering centrifuges with polymer addition. The digester 
supernatant and centrate are combined with the primary effluent for repeated biological treatment. 
Prior to the ozone upgrade, Site H operated parallel pilot-scale treatment trains to 
quantify the net benefits of preozonation on membrane fouling. Both 22-gpm treatment trains 
included MF (Pall Corp., Port Washington, NY) and RO (Hydranautics, Oceanside, CA), but the 
experimental treatment train also included upstream ozonation (Ozonia, Leonia, NJ; O3 = 4.4-
11.7 mg/L; O3/TOC = 0.3-1.5). To control biological fouling, sodium hypochlorite was dosed 
immediately upstream of the each set of MF membranes to achieve a total chlorine residual of 3-
5 mg/L as Cl2. Recall that the matrix is non-nitrified secondary effluent so residual ammonia is 
always present. Samples were collected from pilot-scale versions of the treatment processes 
depicted in Figure S16 to evaluate the potential impacts of ozonation on NDMA in the finished 
effluent. The sampling locations are summarized in Table S27. Of the target nitrosamines, only 
NDMA was monitored during the pilot-scale study.  
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Table S27. Sampling locations for Site H (CA) 
Sample Description 
1 Secondary Effluent 
2 Ozone Effluent 
3 Ozone MF Filtrate 
4 Ozone RO Permeate 
5 MF Filtrate 
6 RO Permeate 
 
 
Figure S16. Treatment train schematic and sampling locations for Site H (CA) 
 
 
Table S28. EfOM characterization for pilot treatment train at Site H (CA) (July - October 2011) 
Parameter July 
Secondary 
Effluent 
July 
Ozone 
Effluent 
August 
Secondary 
Effluent 
August 
Ozone 
Effluent 
September 
Secondary 
Effluent 
September 
Ozone 
Effluent 
October 
Secondary 
Effluent 
October 
Ozone 
Effluent 
UV254 (cm-1) 0.211 0.138 0.364 0.209 0.192 0.158 0.212 0.162 
UV280 (cm-1) 0.166 0.092 0.295 0.161 0.144 0.120 0.160 0.114 
TOC (mg/L) 12.5 N/A 11.5 N/A 12.3 N/A 11.8 N/A 
SUVA (L/mg-m) 1.69 N/A 3.17 N/A 1.56 N/A 1.80 N/A 
TF (AFU) 142,724 26,376 239,104 26,413 128,806 62,457 123,057 52,219 
Region 1 (AFU) 62,355 9,804 101,099 9,509 51,083 27,243 51,439 23,164 
Region 2 (AFU) 63,176 12,623 115,245 13,262 59,522 27,050 57,332 23,025 
Region 3 (AFU) 17,192 3,949 22,760 3,643 18,171 8,163 14,286 6,030 
*N/A = Not Available 
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Figure S17. Qualitative comparison of EEMs for Site H (CA) (July - October 2011) 
 
 
 
 
Figure S18. NDMA concentrations at Site H (CA) as a function of influent UV254 absorbance. 
These data represent samples collected weekly from late April 2011 to early November 2011.  
 
  
Note: The arbitrary 
fluorescence scale 
(i.e., AFU) ranges 
from 0.0 to 5.0 in 
each of these EEMs. 
Previous EEMs for 
other sites ranged 
from 0.0 to 1.0. 
Therefore, these 
samples are more 
‘concentrated’ than 
they appear.  
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Figure S19. Ozone-induced NDMA formation at Site H (CA) as a function of ambient NDMA. 
These data represent samples collected weekly from late April 2011 to early November 2011. 
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Text S9. Full-Scale Site I (NV) 
The average daily flow at Site I is 100 mgd. The treatment train includes bar screens; grit 
removal; ferric chloride and polymer addition; primary clarifiers; activated sludge (SRT = 7 days) 
with nitrification, denitrification, and biological phosphorus removal; and secondary clarifiers. A 
portion of the flow is then treated with alum addition, dual-media filters, and UV disinfection (40 
mJ/cm2) prior to discharge to a nearby surface water. The remainder of the flow is treated with 
alum addition, flocculation, tertiary clarifiers, dual-media filters, and either UV disinfection (40 
mJ/cm2) for surface water discharge or sodium hypochlorite for irrigation applications. Solids 
handling processes include ferric chloride addition, sludge storage tanks, dissolved air flotation 
thickeners, and dewatering centrifuges. The centrate is recombined with the primary effluent for 
repeated biological treatment.  
 
Table S29. Sampling locations for Site I (NV) 
Sample Description 
1 Primary Effluent 
2 Secondary Effluent 
3 Filter Effluent 
4 Chlorinated Effluent 
5 UV Effluent 
6 Field Blank 
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Figure S20. Treatment train schematic and sampling locations for Site I (NV) 
 
 
 
Table S30. Water Quality Data for Site I (NV) (March 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Chlorinated 
Effluent 
UV 
Effluent 
TSS (mg/L) 106 9 0 0 
BOD (mg/L) 196 2 0 0 
PO4 (mg-P/L) 2.33 0.052 0.016 0.014 
TP (mg/L) 4.52 0.37 0.058 0.060 
NH3 (mg-N/L) 27 0.05 0 0 
TN (mg/L) 30 13 14 13 
 
 
Table S31. EfOM characterization for Site I (NV) (March 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Filter 
Effluent 
Chlorinated 
Effluent 
UV 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.401 0.128 0.118 0.093 0.116 < 0.002 
UV280 (cm-1) 0.307 0.097 0.090 0.061 0.090 < 0.002 
DOC (mg/L) 59 7.0 N/A N/A N/A N/A 
TOC (mg/L) N/A N/A 5.8 5.8 5.8 < 0.2 
SUVA (L/mg-m) 0.680 1.83 2.03 1.60 2.00 N/A 
TN (mg/L) 30 13 13 14 13 < 0.2 
TF (AFU) 140,716 37,039 30,639 11,450 30,537 1,186 
Region 1 (AFU) 84,235 14,750 10,661 4,980 10,478 904 
Region 2 (AFU) 46,672 16,060 14,403 4,831 14,451 235 
Region 3 (AFU) 9,809 6,229 5,575 1,639 5,608 46 
*N/A = Not Applicable 
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Figure S21. Qualitative comparison of EEMs for Site I (NV) (March 2012) 
 
 
Table S32. Nitrosamines data for Site I (NV) 
Nitrosamine Primary 
Effluent 
Secondary 
Effluent 
Filter 
Effluent 
Chlorinated 
Effluent 
UV 
Effluent 
Field 
Blank 
NDMA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 5.0 < 2.5 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 20 < 10 
NMOR (ng/L) < 50 11 13 11 < 10 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 20 < 10 
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Text S10. Full-Scale Site J1 (NV)  
The average daily flow at Site J1 is 75 mgd, which is split between two treatment trains. 
Both treatment trains share bar screens, grit removal, and ferric chloride addition, and then the 
first treatment train continues with ferric chloride addition, primary clarifiers, trickling filters, 
secondary clarifiers, activated sludge with nitrification (SRT = 6-8 days), and tertiary clarifiers. 
After grit removal and ferric chloride addition, the second treatment train continues with primary 
clarifiers; activated sludge (SRT = 6-8 days) with nitrification, denitrification, and biological 
phosphorus removal; and secondary clarifiers. The flows then recombine for alum addition, 
media filtration, and sodium hypochlorite. The finished effluent is either discharged to a nearby 
surface water or used for irrigation applications. Solids handling processes include gravity 
thickeners, sludge holding tanks, anaerobic digesters, and dewatering centrifuges. Digester 
supernatant and centrate are returned to the headworks for repeated treatment.  
 
Table S33. Sampling locations for Site J1 (NV) 
Sample Description 
1 Primary Effluent 
2 Secondary Effluent 
3 Filter Effluent 
4 Chlorinated Effluent 
5 Field Blank 
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Figure S22. Treatment train schematic and sampling locations for Site J1 (NV) 
 
 
Table S34. Water quality data for Site J1 (NV) (March 2012) 
Parameter Secondary 
Effluent 
Filter 
Effluent 
Chlorinated 
Effluent 
TSS (mg/L) 126 3.6 < 2 
BOD (mg/L) 181 6 <2 
PO4 (mg-P/L) 2.37 0.10 0.19 
TP (mg/L) 4.17 0.20 0.24 
Alkalinity (mg/L CaCO3) 252 111 106 
NH3 (mg-N/L) N/A 0.3 < 0.1 
TON (mg-N/L) N/A 14.4 22.2 
TKN (mg-N/L) N/A 7.6 1.0 
TN (mg/L) 15 22 20 
*N/A = Not Applicable 
 
Table S35. EfOM characterization for Site J1 (NV) (March 2012) 
Parameter Primary 
Effluent 
Secondary 
Effluent 
Filter 
Effluent 
Chlorinated 
Effluent 
Field 
Blank 
UV254 (cm-1) 0.372 0.133 0.134 0.101 < 0.002 
UV280 (cm-1) 0.292 0.099 0.102 0.067 < 0.002 
DOC (mg/L) 31 7.7 N/A N/A N/A 
TOC (mg/L) N/A N/A 6.9 6.9 < 0.2 
SUVA (L/mg-m) 1.20 1.73 1.94 1.46 N/A 
TN (mg/L) 34 15 22 20 < 0.2 
TF (AFU) 73,310 20,313 20,324 8,896 99 
Region 1 (AFU) 43,629 7,718 7,470 3,937 75 
Region 2 (AFU) 24,453 9,124 9,289 3,716 19 
Region 3 (AFU) 5,227 3,472 3,565 1,243 5 
*N/A = Not Applicable  
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Figure S23. Qualitative comparison of EEMs for Site J1 (NV) (March 2012) 
 
 
Table S36. Nitrosamines data for Site J1 (NV) 
Nitrosamine Primary Effluent 
Secondary 
Effluent 
Filter 
Effluent 
Chlorine 
Effluent 
Field 
Blank 
NDMA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 2.5 
NMEA (ng/L) < 25 < 5.0 < 5.0 < 5.0 < 2.5 
NDEA (ng/L) < 50 < 10 < 10 < 10 < 5.0 
NDPrA (ng/L) < 100 < 20 < 20 < 20 < 10 
NMOR (ng/L) < 50 11 < 10 < 10 < 5.0 
NDBA (ng/L) < 100 < 20 < 20 < 20 < 10 
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Text S11. Pilot-Scale Site J2 (NV) 
Site J2 treated primary effluent from full-scale Site J1 (described earlier) with a 22-gpm 
pilot-scale membrane bioreactor (MBR; Hydranautics). The MBR was operated at SRTs ranging 
from 2-20 days to simulate BOD removal and nitrification/denitrification. The MBR filtrate was 
then split between parallel 10-gpm trains. The control train included RO only (Hydranautics), 
and the experimental train, which was used to quantify the net benefits of preozonation on 
membrane fouling, included ozone (HiPOx, APTwater, Pleasant Hill, CA; O3/DOC = 0.0-1.0) 
and RO (Hydranautics). For this study, nitrosamine samples were only collected from the MBR 
filtrate and the ozone effluent, but general water quality data are also provided for the MBR 
influent in Tables S38.  
 
Table S37. Sampling locations for Site J2 (NV) 
Sample Description 
1 MBR Filtrate 
2 Ozone Effluent 
3 Field Blank 
 
 
Figure S24. Treatment train schematic and sampling locations for Site J2 (NV) 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
S36 
Table S38. Water quality data for Site J2 (NV) 
Parameter 
(units) 
MBR  
Influenta 
Filtrate 
SRT=2.4 d 
Filtrate 
SRT=18.8 d 
Field 
Blank 
COD (mg/L) 275 54 <20 N/A 
BOD (mg /L) 124 <2 <2 N/A 
PO4 (mg/L) 2.32 0.10 0.09 N/A 
TP (mg/L) 3.57 0.30 0.12 N/A 
NH3 (mg-N/L) 27 22 2.6 N/A 
TON (mg-N/L) < 0.2 < 0.2 7.8 N/A 
TKN (mg-N/L) 35 N/A 3.1 N/A 
TN (mg/L) 35 19 13 <0.2 
a Average values from pilot operation from April 2012 to February 2013 
 
Table S39. EfOM characterization for Site J2 (NV) with SRT = 2.4 days 
Parameter 
(units) 
O3/DOC Field 
Blank 0.00 0.20 0.50 1.00 
UV254 (cm-1) 0.108 0.063 0.051 0.044 < 0.002 
UV280 (cm-1) 0.083 0.040 0.030 0.025 < 0.002 
DOC (mg/L) 4.7 4.7 4.5 4.3 < 0.2 
SUVA (L/mg-m) 2.30 1.34 1.13 1.02 N/A 
TN (mg/L) 19 19 19 20 < 0.2 
TF (AFU) 9,544 1,855 1,083 691 4.2 
Region 1 (AFU) 1,670 269 133 63 0.4 
Region 2 (AFU) 3,109 674 402 260 2.3 
Region 3 (AFU) 4,765 912 548 368 1.6 
 
Table S40. EfOM characterization for Site J2 (NV) with SRT = 18.8 days 
Parameter 
(units) 
O3/DOC Field 
Blank 0.00 0.20 0.50 1.00 
UV254 (cm-1) 0.103 0.091 0.066 0.050 < 0.002 
UV280 (cm-1) 0.078 0.064 0.041 0.030 < 0.002 
DOC (mg/L) 5.2 5.2 5.2 6.3 < 0.2 
SUVA (L/mg-m) 1.98 1.74 1.26 0.787 N/A 
TN (mg/L) 13 15 14 13 < 0.2 
TF (AFU) 8,226 4,340 1,858 836 N/A 
Region 1 (AFU) 1,500 858 298 103 N/A 
Region 2 (AFU) 2,662 1,484 649 295 N/A 
Region 3 (AFU) 4,063 1,998 911 439 N/A 
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Figure S25. Qualitative comparison of EEMs for the MBR filtrate from Site J2 (NV). Each 
image reflects a different O3/DOC ratio for an SRT of either 2.4 days (i.e., BOD removal mode) 
or 18.8 days (i.e., nitrification/denitrification mode). 
 
 
Table S41. Nitrosamines data for Site J2 (NV) 
 SRT = 2.4 days SRT = 18.8 days 
Nitrosamine O3/DOC O3/DOC 0.00 0.20 0.50 1.00 0.00 0.20 0.50 1.00 
NDMA (ng/L) 7.4 25 29 28 < 5.0 < 5.0 9.7 14 
NMEA (ng/L) < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 < 5.0 
NDEA (ng/L) 11 < 10 < 10 < 10 < 10 < 10 < 10 < 10 
NDPrA (ng/L) < 20 < 20 < 20 < 20 < 20 < 20 < 20 < 20 
NMOR (ng/L) < 10 11 < 10 < 10 < 10 < 10 < 10 < 10 
NDBA (ng/L) < 20 < 20 < 20 < 20 < 20 < 20 < 20 < 20 
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Text S12. Analytical Methods 
Nitrosamine analysis was performed with isotope dilution using a modified version of 
United States (U.S.) Environmental Protection Agency (EPA) method 521 (Holady et al., 2012). 
Matrix interference resulted in unreliable quantification for NPYR and NPIP, particularly in 
primary effluent, and NDPhA proved to be unstable over the 14-day holding period (see Table 
S42). Therefore, monitoring efforts were limited to NDMA, NMEA, NDEA, NDPrA, NMOR, 
and NDBA. Corresponding isotopes, precursor and product ions used for quantitation and 
confirmation, molecular weights, and method reporting limits (MRLs) are summarized in Table 
S43. Matrix-specific MRLs are also listed in the preceding summary tables.  
 
Table S42. Summary of results from 14-day nitrosamine holding study. Triplicate samples were 
spiked with approximately 1 µg/L of each target nitrosamine. 
Nitrosamine Deionized Water Primary Effluent 
0 Days 7 Days 14 Days 0 Days 7 Days 14 Days 
NDMA 930±20a 893±35 937±25 953±31 877±6 897±35 
NMEA 983±21 1000±0 997±6 957±38 973±25 953±57 
NDEA 1003±87 877±59 957±67 890±20 813±32 830±27 
NDPrA 920±10 953±6 1000±100 910±20 870±36 893±179 
NMOR 947±76 990±17 930±0 887±29 840±10 860±46 
NDBA 1017±144 880±10 900±12 870±105 787±29 810±53 
NDPhA 937±47 213±12 <100±0 853±76 233±21 <100±0 
a ±1 standard deviation based on triplicate spiked samples 
 
Automated solid phase extraction (ASPE) was performed using a Dionex AutoTrace 
workstation (Thermo Scientific, Sunnyvale, CA, USA). Samples were spiked with 100 µL of 
isotope mix at 0.5-2.5 mg/L for a final concentration of 100-500 µg/L in the final extract. Pre-
packed activated carbon cartridges (Resprep 521, Restek, Bellefonte, PA, USA) were 
sequentially conditioned with 5 mL of dichloromethane (DCM), 5 mL of methanol, and 10 mL 
of reagent grade water with flow rates of 15 mL/min. Samples were loaded at a rate of 15 
mL/min. Cartridges were rinsed with 5 mL of reagent grade water with a flow rate of 20 mL/min 
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and dried for 10 min with nitrogen gas. Analytes were eluted with 10 mL of DCM into 15 mL 
conical vials (Dionex) with a flow rate of 5 mL/min. Extracts were evaporated under nitrogen 
gas to approximately 2 mL. Water was then removed from the DCM extracts by passing the 2 
mL extract through a DryDisk separation membrane (Horizon Technology, Salem, NH, USA). 
The DCM extract was collected and concentrated to a final volume of 500 µL with nitrogen gas, 
resulting in a 1:2000 concentration factor. 
 
Table S43. Target nitrosamines and corresponding isotopes. 
 
 
A Varian (Walnut Creek, CA) CP-3800 Gas Chromatograph with a CP-8400 auto 
sampler was used for all analyses. The injector (Varian 1177) was operated in splitless mode 
with a Siltek™ deactivated glass liner (Restek, Bellefonte, PA) and set at a temperature of 200°C.  
Analytes were separated on a 30 m x 0.32 mm ID x 1.4 µm DB624 column (J & W, Agilent, 
Palo Alto, CA) using a 1.4 mL/min helium flow with an initial pressure pulse of 35 psi for 0.85 
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min. The temperature program was as follows: 35°C, hold for 1.0 min; 35-120°C at 5°C/min; 
120-145°C at 3°C/min; 145-250°C at 35°C/min, hold for 4.64 min. An injection volume of 2 µL 
was used for all analyses. The transfer line was set at 240°C.    
Analysis was performed using a Varian 4000 ion trap mass spectrometer (Walnut Creek, 
CA). All analyses were performed using multiple reaction monitoring (MRM) in positive 
chemical ionization mode using liquid methanol. Some of the nitrosamines did not exhibit a 
second product ion in sufficient abundance for transition confirmation and therefore only have 
one quantitation transition. Due to thermal degradation upon injection, NDPhA was analyzed as 
diphenylamine during the 14-day holding study. MRLs were established at 3 to 5 times the 
calculated method detection limit (MDL) (n=12). A field blank was collected for each sampling 
event, extracted, and analyzed. A laboratory reagent blank was also included in each extract 
batch. Acceptable average percent recoveries were limited to 70-130%, and acceptable relative 
standard deviations (RSDs) were limited to 30% for replicate samples. Average percent 
recoveries and RSDs in reagent water, finished drinking water, surface water, and tertiary 
wastewater effluent are summarized in Table S44. 
 
Table S44. Average recovery and relative standard deviations (RSDs) for target nitrosamines 
(spiked at 25 ng/L) in various water matrices (n=6). 
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Trace analysis grade methanol and DCM were obtained from Burdick and Jackson 
(Muskegon, MI, USA). Sodium azide was purchased from Fisher Chemicals (Fisher Scientific, 
Fair Lawn, NJ, USA), and sodium thiosulfate was purchased from EM Science (Merck KGaA, 
Darnstadt, Germany). Reagent grade water was prepared by using a Milli-Q Gradient water 
purification system (Millipore, Billerica, MA, USA). Nitrosamine standards were purchased 
from Ultra Scientific (Kingstown, RI, USA), whereas isotopically labeled nitrosamines were 
purchased from Cambridge Isotope Laboratories (Andover, MA, USA). Working stock solutions 
of nitrosamines and isotopically labeled nitrosamines were made in DCM. Appropriate dilutions 
were made in methanol for ASPE spiking solutions (i.e., nitrosamine spike mix and isotopically 
labeled standards). Calibration standards (minimum of seven ranging from 1.0 to 500 µg/L) were 
made in DCM and were replaced every three months. All stock solutions, ASPE spiking 
solutions, and calibration standards were stored at -20 °C. 
The quantification of subtle differences in the EEMs involved the use of the FRI method 
(Chen et al., 2003), which was modified and described previously (Gerrity et al., 2011; Stanford 
et al., 2011). The FRI concept uses specific regions of the EEM to identify (and quantify) 
specific organic matter fractions. The EEM integration included three regions representing (I) 
microbial byproducts, proteins, and biopolymers; (II) fulvic-like substances; and (III) humic-like 
substances.  These regions are defined in Table S45 and illustrated in Figure 26. 
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Table S45. Fluorescence region definitions 
Region Excitation/Emission Range Description 
I EX240-300/Em280-390 Microbial byproducts, proteins, biopolymers 
II EX240-300/Em390-580 Fulvic-like compounds 
III EX300-470/Em317-580 Humic-like compounds 
 
 
Figure S26. Illustration of fluorescence regions 
 
